Effects of Liraglutide on Cognition, Chronic Inflammation and Glycemic Control in Overweight and Obese, HIV-infected Subjects With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 02 Sep 2016 Status changed from not yet recruiting to recruiting.
- 20 Apr 2016 New trial record